These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 714275)

  • 61. [Antibiotic therapy].
    Schmid F; Haus E; Schreiber A
    Fortschr Med; 1973 Apr; 91(10):430-4 contd. PubMed ID: 4700410
    [No Abstract]   [Full Text] [Related]  

  • 62. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of sisomicin and gentamicin in the treatment of serious systemic infections.
    Leal del Rosal P; Leal del Rosal L; Riosvelasco Carrasco AG; Aguirre Rascon E
    Curr Med Res Opin; 1980; 6(10):663-9. PubMed ID: 7428404
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Bacteriological, pharmacological and clinical comparison between amoxycillin and ceftriaxone in the treatment of 300 purulent meningitis ].
    Cadoz M; Denis F; Guerma T; Prince-David M; Diop Mar I
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):522-5. PubMed ID: 6289230
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [A single daily injection of ceftriaxone for treating suppurated meningitis in infants and children. Apropos of 31 cases].
    Floret D; Melki I; Janin N; Reverdy E
    Pediatrie; 1987; 42(3):199-204. PubMed ID: 3658622
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci].
    Potel G; Touzé MD; Meignier M; Reynaud A; Baron D
    Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of bacterial meningitis during 1992-1996 in Poland.
    Tyski S; Grzybowska W
    Cent Eur J Public Health; 1998 Aug; 6(3):225-30. PubMed ID: 9787925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibiotic-induced meningitis.
    Br Med J; 1973 Aug; 3(5876):366. PubMed ID: 4730182
    [No Abstract]   [Full Text] [Related]  

  • 69. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
    Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
    Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kinetics of netilmicin in man.
    Pechere JC; Dugal R; Pechere MM
    Clin Pharmacol Ther; 1978 Jun; 23(6):677-84. PubMed ID: 648080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sisomicin: Bacteriological and clinical evaluation.
    Klastersky J; Hensgens C; Gérad M; Daneau D
    J Clin Pharmacol; 1975 Apr; 15(4 Pt 1):252-61. PubMed ID: 1092723
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative study of three routes of administration of sisomicin.
    Meunier-Carpentier F; Staquet M; Klastersky J
    J Clin Pharmacol; 1976; 16(11-12):625-30. PubMed ID: 993357
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Investigation of the c. s. fluid levels of two newer antibiotics; cefazolin and sisomicin (author's transl)].
    Friedrich H; Pelz K; Hänsel-Friedrich G
    Neurochirurgia (Stuttg); 1977 Jul; 20(4):123-31. PubMed ID: 895972
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pharmacokinetic investigations on sisomicin in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter J
    Monatsschr Kinderheilkd (1902); 1978 Aug; 126(8):512-7. PubMed ID: 683201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Sisomicin pharmacokinetics after a single intravenous dose].
    Lypka A; Orłowski T; Lazowski J; Wierzba K
    Wiad Lek; 1979 Sep; 32(17):1223-8. PubMed ID: 506260
    [No Abstract]   [Full Text] [Related]  

  • 78. [Laboratory methods of controlling the effectiveness of antibacterial therapy].
    Treskina OS; Levina EN; Slepchenko LM
    Antibiot Med Biotekhnol; 1985 Jun; 30(6):456-9. PubMed ID: 4062272
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Evaluation of two regimens of sisomicin treatment in bacterial infections (author's transl)].
    Hatala M; Spousta J; Kvĕton J; Kubelka Z; Sesták P; Modr Z
    Cas Lek Cesk; 1978 May; 117(19):607-10. PubMed ID: 679238
    [No Abstract]   [Full Text] [Related]  

  • 80. Sisomicin in the treatment of urinary tract infections.
    Richmond JM; Walker RG; Kincaid-Smith P
    Med J Aust; 1979 Oct; 2(7):375-6. PubMed ID: 390345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.